PT1275377E - Granulados contendo substancias lipossoluveis e sua preparacao - Google Patents

Granulados contendo substancias lipossoluveis e sua preparacao

Info

Publication number
PT1275377E
PT1275377E PT01202657T PT01202657T PT1275377E PT 1275377 E PT1275377 E PT 1275377E PT 01202657 T PT01202657 T PT 01202657T PT 01202657 T PT01202657 T PT 01202657T PT 1275377 E PT1275377 E PT 1275377E
Authority
PT
Portugal
Prior art keywords
preparation
substances
granulates
water
liposoluvable
Prior art date
Application number
PT01202657T
Other languages
English (en)
Inventor
Alberto Reiner
Original Assignee
Fidia Farmaceutici
Applied Pharma Res
Ipsen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici, Applied Pharma Res, Ipsen Spa filed Critical Fidia Farmaceutici
Publication of PT1275377E publication Critical patent/PT1275377E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
PT01202657T 2001-07-11 2001-07-11 Granulados contendo substancias lipossoluveis e sua preparacao PT1275377E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01202657A EP1275377B1 (en) 2001-07-11 2001-07-11 Granulates containing liposoluble substances and process of preparation thereof

Publications (1)

Publication Number Publication Date
PT1275377E true PT1275377E (pt) 2003-11-28

Family

ID=8180628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01202657T PT1275377E (pt) 2001-07-11 2001-07-11 Granulados contendo substancias lipossoluveis e sua preparacao

Country Status (21)

Country Link
US (1) US7615547B2 (pt)
EP (1) EP1275377B1 (pt)
JP (1) JP2004536118A (pt)
KR (1) KR100877628B1 (pt)
AT (1) ATE243028T1 (pt)
AU (1) AU2002328866B2 (pt)
BR (1) BR0211081A (pt)
CA (1) CA2452386C (pt)
DE (1) DE60100389T2 (pt)
DK (1) DK1275377T3 (pt)
ES (1) ES2199202T3 (pt)
HR (1) HRP20040010A2 (pt)
IL (1) IL159346A0 (pt)
MX (1) MXPA04000211A (pt)
NO (1) NO20040043L (pt)
NZ (1) NZ530473A (pt)
PL (1) PL204963B1 (pt)
PT (1) PT1275377E (pt)
RU (1) RU2288704C2 (pt)
WO (1) WO2003005989A2 (pt)
ZA (1) ZA200309680B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579319B2 (en) 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US20050080486A1 (en) 2000-11-29 2005-04-14 Fallin T. Wade Facet joint replacement
US7753937B2 (en) 2003-12-10 2010-07-13 Facet Solutions Inc. Linked bilateral spinal facet implants and methods of use
EP1795183B1 (en) * 2005-12-09 2009-07-15 Teva Pharmaceutical Industries, Inc. Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation
WO2008078922A1 (en) * 2006-12-22 2008-07-03 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
KR102039494B1 (ko) * 2011-12-22 2019-11-01 라이프 테크놀로지스 코포레이션 세포 배양 배지 및 방법
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2018233781A1 (en) * 2017-06-23 2018-12-27 Medcan Pharma A/S SACHET OF CANNABINOIDS
CN108309933A (zh) * 2018-03-19 2018-07-24 青岛国海生物制药有限公司 一种口服醋酸甲地孕酮纳米混悬液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
JPH0449232A (ja) 1990-06-15 1992-02-18 Fujisawa Pharmaceut Co Ltd 懸濁用組成物または懸濁液並びにそれらの製造法
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
RU2150942C1 (ru) 1993-10-01 2000-06-20 Синтекс (Ю.ЭС.ЭЙ.) Инк. Оральные суспензии, содержащие высокие дозы мофетила микофенолята
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
FR2730163B1 (fr) 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
EP0914822A4 (en) 1996-03-14 2002-08-07 Bayer Ag PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
ID29270A (id) 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form

Also Published As

Publication number Publication date
DE60100389D1 (de) 2003-07-24
EP1275377B1 (en) 2003-06-18
BR0211081A (pt) 2004-12-14
IL159346A0 (en) 2004-06-01
HRP20040010A2 (en) 2004-06-30
US20040009232A1 (en) 2004-01-15
ES2199202T3 (es) 2004-02-16
DE60100389T2 (de) 2004-05-19
NZ530473A (en) 2006-02-24
RU2004103853A (ru) 2005-03-27
RU2288704C2 (ru) 2006-12-10
AU2002328866B2 (en) 2007-02-15
PL369294A1 (en) 2005-04-18
EP1275377A1 (en) 2003-01-15
WO2003005989A2 (en) 2003-01-23
CA2452386C (en) 2011-01-18
WO2003005989A3 (en) 2003-05-01
KR100877628B1 (ko) 2009-01-07
DK1275377T3 (da) 2003-10-06
US7615547B2 (en) 2009-11-10
ATE243028T1 (de) 2003-07-15
ZA200309680B (en) 2004-12-22
JP2004536118A (ja) 2004-12-02
NO20040043L (no) 2004-01-06
CA2452386A1 (en) 2003-01-23
HRP20040010B1 (pt) 2007-01-31
MXPA04000211A (es) 2005-03-07
KR20040018440A (ko) 2004-03-03
PL204963B1 (pl) 2010-02-26

Similar Documents

Publication Publication Date Title
PT1275377E (pt) Granulados contendo substancias lipossoluveis e sua preparacao
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
FI954905A0 (fi) Kiinteä farmaseuttinen koostumus, joka sisältää täyteainetta, joka kykenee sitomaan vettä
ATE526059T1 (de) Wasserenthaltende puderzubereitung, verfahren zu deren herstellung und kosmetische zubereitung diese enthaltend
WO2001032132A3 (en) Process for making toothpaste using agglomerated dispersible polymers
BR0214254A (pt) Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
ES2079389T3 (es) Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada.
ES2190819T3 (es) Procedimiento de preparacion de formulaciones galenicas noveles que contienen fenobrinato, formulaciones galenicas asi obtenidas y sus aplicaciones.
DE69939555D1 (de) Granuliertes Brotverbesserungmittel zur Herstellung von Teigwaren
BR9808037A (pt) Mistura de sólidos, e, processo para a preparação de formulações herbicidas.
PT1166645E (pt) Amido aglomerado e produto a base de maltodextrina para a preparacao de alimentos
ATE226174T1 (de) Mischkapsel
DE50106179D1 (de) Carotinoidtrockenpulver mit einer Multi-Kern Struktur
ATE358469T1 (de) Verfahren zur herstellung fester zubereitungen wasserlöslicher, schwer wasserlöslicher oder wasserunlöslicher wirkstoffe
EA200600085A1 (ru) Капсулы флуконазола с улучшенным высвобождением
DE60020871D1 (de) Formulierungen mit verlängerter freisetzung zur implantation
RU2001100615A (ru) Способ применения костного цемента с биологически активными веществами
EA200200866A1 (ru) Диспергирующийся и быстро гидратирующийся биополимер
ES2171145A1 (es) Formulacion aceleradora de la descomposicion de materia organica en general y de restos animales en particular; procedimiento para su preparacion y aplicaciones.
BR0114734A (pt) 3,4-dihidropirido [1, 2-a] pirimidinas substituìdas
Jiang et al. Gray System Study on the Influence of Particle Size Distribution of Fly Ash on Strength of Fly Ash Cement
Botaki et al. Effect of radiation exposure on primary processes of plastic deformation of ionic crystals and cements; Vliyanie radiatsionnogo vozdejstviya na pervichnye protsessy plasticheskoj deformatsii ionnykh kristallov i metallokeramiki
Radchenko et al. Gamma-radiation sources on the basis of iridium-192, cobalt-60, selenium-75 for industry and medicine; Istochniki gamma-izlucheniya na osnove iridiya-192, kobal'ta-60, selena-75 dlya promyshlennosti i meditsiny